Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rinaldo

Showing results (311-320 of 324) with videos related to

Pageof 33
Sort By:
Plos One|April 5, 2013
The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohortsMatthew R Gingo, G K Balasubramani, Lawrence Kingsley, et al.
The Journal of Infectious Diseases|November 30, 2023
SARS-CoV-2 mRNA Vaccines Induce Greater Complement Activation and Decreased Viremia and Nef Antibodies in Men With HIV-1Dylan J Tuttle, Priscila M S Castanha, Amro Nasser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2018
Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral TherapyConstance A Benson, Janet W Andersen, Bernard J C Macatangay, et al.
The Journal of Infectious Diseases|April 28, 2010
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trialDavid M Asmuth, Robert L Murphy, Susan L Rosenkranz, et al.
Ebiomedicine|January 15, 2021
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopesTatiana M Garcia-Bates, Mariana L Palma, Renee R Anderko, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL responseJune Kan-Mitchell, Melissa Bajcz, Keri L Schaubert, et al.
Journal of Virology|September 7, 2007
Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replicationArne Schneidewind, Mark A Brockman, Ruifeng Yang, et al.
Ebiomedicine|May 5, 2026
Multi-omics analysis of the gut microbiome and carotid artery atherosclerosis in men with and without HIVZheng Wang, Yi Wang, Brandilyn A Peters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2013
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimatesSuzanne E Ohmit, Mark G Thompson, Joshua G Petrie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 13, 2012
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working GroupKevin P High, Mark Brennan-Ing, David B Clifford, et al.
Pageof 33

Showing results (311-320 of 324) with videos related to

Sort By:
Pageof 33
Plos One|April 5, 2013
The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohortsMatthew R Gingo, G K Balasubramani, Lawrence Kingsley, et al.
The Journal of Infectious Diseases|November 30, 2023
SARS-CoV-2 mRNA Vaccines Induce Greater Complement Activation and Decreased Viremia and Nef Antibodies in Men With HIV-1Dylan J Tuttle, Priscila M S Castanha, Amro Nasser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2018
Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral TherapyConstance A Benson, Janet W Andersen, Bernard J C Macatangay, et al.
The Journal of Infectious Diseases|April 28, 2010
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trialDavid M Asmuth, Robert L Murphy, Susan L Rosenkranz, et al.
Ebiomedicine|January 15, 2021
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopesTatiana M Garcia-Bates, Mariana L Palma, Renee R Anderko, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL responseJune Kan-Mitchell, Melissa Bajcz, Keri L Schaubert, et al.
Journal of Virology|September 7, 2007
Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replicationArne Schneidewind, Mark A Brockman, Ruifeng Yang, et al.
Ebiomedicine|May 5, 2026
Multi-omics analysis of the gut microbiome and carotid artery atherosclerosis in men with and without HIVZheng Wang, Yi Wang, Brandilyn A Peters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2013
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimatesSuzanne E Ohmit, Mark G Thompson, Joshua G Petrie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 13, 2012
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working GroupKevin P High, Mark Brennan-Ing, David B Clifford, et al.
Pageof 33